CORC

浏览/检索结果: 共13条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Risk Factors for Developing T790M Mutation in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer 会议论文
作者:  Ouyang, W.;  Xie, C.
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
Risk Factors for Developing T790M Mutation in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer 会议论文
作者:  Ouyang, W.;  Xie, C.
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
Efficacy and Safety of Osimertinib in EGFR T790M-Positive Advanced NSCLC Patients with Brain Metastases (APOLLO Study) 会议论文
作者:  Xing, L.;  Pan, Y.;  Shi, Y.;  Shu, Y.;  Feng, J.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS stud 会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:  Zhou, Q.;  Zhang, H.;  Jiang, L.;  Shi, Y.;  Chen, Y.
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/03
ASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test 会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:  Freitas, H. C.;  Park, K.;  Kim, D-W.;  Tiseo, M.;  Hochmair, M. J.
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
LC-MS/MS法同时测定人血浆中AST2818和去甲基代谢物 会议论文
作者:  刘晓云;  李卫;  张逸凡;  陈笑艳;  钟大放
收藏  |  浏览/下载:61/0  |  提交时间:2019/01/08
Pharmacokinetics of Osimertinib (AZD9291) in Chinese Patients with Advanced NSCLC: A Phase I Study 会议论文
作者:  Cao, Junning;  Chang, Jianhua;  Zhang, Clara;  Leaw, Shiang Jiin;  Wang, Jia
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Open label, multi-center, prospective study to investigate the efficacy and safety of osimertinib in brain metastases from patients with EGFR T790M positive NSCLC who have received prior therapy with an EGFR-TKI (APOLLO Study, NCT02972333) 会议论文
ANNALS OF ONCOLOGY, 2017-04-01
作者:  Wang, L.;  Xing, L.;  Cao, L.;  Wang, X.;  Feng, J.
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/04
Detect T790M in cell free tumor DNA of Chinese advanced non-small cell lung cancer adenocarcinoma patients by different platforms and evaluate clinical outcomes of T790M positive patients with osimertinib monotherapy 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Liang, Zhiyong;  Cheng, Ying;  Chen, Yuan;  Liu, Weiping;  Lu, You
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
Open label, multi-center, prospective study to investigate the efficacy and safety of osimertinib in brain metastases from patients with EGFR T790M positive NSCLC who have received prior therapy with an EGFR-TKI (APOLLO Study, NCT02972333) 会议论文
European Lung Cancer Conference (ELCC), MAY 05-08, 2017
作者:  Wang, L.;  Xing, L.;  Cao, L.;  Wang, L.;  Wang, X.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/31


©版权所有 ©2017 CSpace - Powered by CSpace